| 查看: 2495 | 回复: 4 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
cherishjy木虫 (小有名气)
|
[求助]
第一次投sci，molecules，editor回复我的邮件，怎么回复？ 已有1人参与
|
||
|
assistant editor回复如下： 1. Molecules is an open access journal with publishing fees of 1800 CHF for an accepted paper (see http://www.mdpi.com/about/apc/ for details). A discount may apply if your institute has established an institutional membership with MDPI. For more information, see http://www.mdpi.com/about/memberships. An additional fee may apply if extensive formatting or English editing (for some MDPI journals) must be undertaken by the Editorial Office. For more information please refer to: http://www.mdpi.com/about/apc/. See http://www.mdpi.com/about/openaccess/ for more information about open access publishing. Please confirm that you support open access publishing which allows unlimited access to your published paper and that you will pay the publishing fee if the paper is accepted. Please also let us know if you wish to use our English editing service. 2. Manuscript and copyright issues a. If material from other publications is reproduced in your manuscript, please provide proof that you have obtained the necessary copyright permission. Please refer to our Rights & Permissions website: http://www.mdpi.com/authors/rights/. b. Your manuscript is accepted for processing on the understanding that it has not been published elsewhere (or submitted to another journal). Exceptions to this rule are papers containing material disclosed at conferences. Please also confirm that for papers submitted by authors from various institutions all authors are familiar with and agree with the contents of the manuscript. We reserve the right to contact all authors to confirm this in case of doubt. Please provide E-mail addresses for all authors and at least one institutional email address for one of the co-authors and specify the name, address and E-mail for invoicing purposes. This article, if accepted, will be an open access article distributed under the terms and conditions of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). MDPI will insert the following note at the end of the published text: 2015 by the authors; licensee MDPI AG, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). We will organize a prompt peer-review of your manuscript as soon as you confirm the above conditions. If accepted, it will be published immediately after copy-editing and professional production. Please do not hesitate to contact us if you have any questions. We look forward to receiving your confirmation soon. 求：如何回复？ |
回复此楼» 收录本帖的淘帖专辑推荐
 sci投稿 |
» 猜你喜欢
291求调剂
已经有7人回复
-
300求调剂
已经有8人回复
-
求调剂推荐
已经有7人回复
-
289 分105500药学专硕求调剂(找B区学校)
已经有4人回复
-
0854求调剂
已经有13人回复
-
初试324 中药学 一志愿天中医 求调剂
已经有3人回复
-
药学求调剂
已经有14人回复
-
327求调剂
已经有27人回复
-
急需调剂
已经有5人回复
-
271求调剂
已经有33人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 初次发SCI遇到问题求助
已经有9人回复
- 本人第一篇SCI文章，编辑的回复让我 看不太懂
已经有13人回复
- 投稿SCI期刊with editor到今天已经14天了，怎么这么长时间！
已经有7人回复
- 第一次投SCI，molecules，Assistant Editor 回复了我的邮件，如何回复她？
已经有10人回复
- springer SCI期刊大修后under review2天后变为editor assigned,已经11天了。
已经有21人回复
- 求助大家帮我鉴定下，这个是不是骗子？非常感谢
已经有30人回复
- 投SCI文章最煎熬的24h-technical check in progress通过之后的with editor
已经有7人回复
- 投国外SCI期刊， handled by Special Issue Managing Guest Editor，啥情况？
已经有11人回复
- 如何回复这个信件！
已经有6人回复
- special issue的决定权是在期刊的chief editor还是在guest editor里呢？
已经有32人回复
- Multmedia tools and applications 投稿求助
已经有7人回复
- 修稿意见怎么回？
已经有13人回复
- 投J Mater Sci Mater Med，2周了，还是Editor Assignment Pending
已经有14人回复
- 皮革SCI 杂志的投稿邮箱地址
已经有8人回复
- 投了一篇SCI论文 with editor 一个月了
已经有15人回复
- ＩＥＴ control theory and applications 投稿请教
已经有7人回复
- 【求助/交流】SCI从入门到精通（转载）
已经有80人回复
a597323034
新虫 (小有名气)
- 应助: 7 (幼儿园)
- 金币: 716.5
- 散金: 50
- 帖子: 77
- 在线: 74小时
- 虫号: 1448942
- 注册: 2011-10-18
- 专业: 地理信息系统
5楼2015-03-10 15:27:56
cherishjy
木虫 (小有名气)
- 应助: 0 (幼儿园)
- 金币: 6589.7
- 散金: 18
- 红花: 1
- 帖子: 219
- 在线: 266.3小时
- 虫号: 958492
- 注册: 2010-03-01
- 性别: MM
- 专业: 肿瘤复发与转移
3楼2015-03-10 10:48:13
4楼2015-03-10 10:49:56
